For medullary thyroid carcinoma (MTC), calcitonin demonstrates the most significant elevation across tumor stages, with values reaching 110.5 ± 35.2 pg/mL at stage IV, reflecting its role as a primary biomarker for this subtype (r = 0.80; p < 0.001). The gene discussed is CALCA; the disease is neoplasm.